Status:
COMPLETED
Gait Training in Post-Stroke Hemiparesis Hemiparesis
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Stroke
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The focus of this study is to optimize the delivery of a combined strength and aerobic training regimen to individuals with post stroke hemiparesis and reduce overuse and inefficiencies associated wit...
Detailed Description
This study will include twenty stroke survivors and twenty healthy adults (total 40 participants) who are 20 years or older. Both groups (stroke vs healthy) will be screened and recruited from a UTMB ...
Eligibility Criteria
Inclusion
- Healthy individuals, ages 20 or older
- Healthy participants will be required to be medically stable
- Healthy participants are able to walk at least 10 meters independently at a comfortable speed without an assistive device
- The participants with a history stroke, ages 20 or older
- Unilateral first stroke of ischemic origin in the carotid artery distribution
- Unilateral first stroke of hemorrhagic origin in the carotid artery distribution
- Diagnosis of stroke at least 6 months prior to participation
- Free of major post-stroke complications (e.g., recurrent stroke, hip fracture, myocardial infarction)
- Living within the community
- The participants with a history stroke are able to ambulate 10 meters with or without assistive devices
Exclusion
- A history of any significant orthopedic problems
- A history of psychiatric or cognitive illness (e.g., bipolar affective disorder, psychosis, schizophrenia, attention deficits, cognitive deficits, or medication refractor depression)
- Neurological problems
- Stroke secondary to subarachnoid hemorrhage or posterior circulation stroke
- Not expected to live more than one year
- Comatose
- Unable to follow 3 step commands
- Amputation
- Poorly controlled diabetes (e.g., foot ulceration)
- Blind
- Progressive neurological diseases
- Comprehensive aphasia
- Medical instability
- Significant musculoskeletal problems
- Congestive cardiac failure
- Unstable angina
- Peripheral vascular disease
- Neuropsychiatric disorders (e.g., dementia, cognitive deficits, and severe depression)
Key Trial Info
Start Date :
July 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2025
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04877249
Start Date
July 9 2021
End Date
March 28 2025
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Health Profession, University of Texas Medical Branch
Galveston, Texas, United States, 77550